|
DNA-cationic lipid complexation:
The development in gene therapy has caused a need for efficient
transfection vectors. Viruses have been used in transfection several
years. During resent years cationic liposomes have begun to be a rival for
viruses due to several advantages, for example nonimmunogenity, low
toxicity and capability to carry large amount of the DNA [1-3]. Still the
properties of the cationic liposomes and the interaction between the DNA
is not known accurately [1, 3]. The knowledge of these complexes also
known as lipoplexes is mainly based on experimental results. There are a
lot of data describing different kinds of biophysical properties of the
systems [4-7]. Some theoretical research has also been done. The aim of
these studies has been to achieve models to describe the interaction
energy and the way of interaction between the DNA and a lipid bilayer or a
lipid monolayer [8-10].
In the computational studies the lipid bilayer has been simulated by using
the Monte Carlo method or Molecular Dynamics [11-13]. Simulations were
made with lipid bilayer, which was in a water box during the simulations
[12, 13]. The effect of the cationic lipid and the DNA was also studied
[11].
In vivo experiments [14, 15] have shown that clinical applications of the
DNA-cationic lipid complexes are effective and safe. Although there are
still several unknown factors affecting the clinical use of these
complexes.
In our research we study the properties of a monolayer which
consists of zwitterionic and cationic lipids. We are using Monte Carlo
and molecular dynamics simulations to help
to understand the interactions in the
experimental system and also the processes, which take place during the
experiment.
Our cationic lipid and DNA related publications:
-
Cationic DMPC/DMTAP Lipid Bilayers: Molecular Dynamics Study,
A.A. Gurtovenko, Michael Patra, Mikko Karttunen, and Ilpo Vattulainen
Biophys. J. 86, 3461-3472 (2004).
[online]
[cond-mat/0312400]
Download
equilibrium configuration and parameters
Selected in July 2004 issue of
Molecular Modeling & Computational Chemistry (MMCC)
- Characterization of Sphingosine-Phosphatidylcholine Monlayers: Effects of DNA,
V. Matti J. Säily, Juha-Matti Alakoskela, Samppa J. Ryhänen, Mikko Karttunen, and Paavo K.J. Kinnunen
Langmuir 19, 8956-8963 (2003)
[Online]
- Computational modeling of DNA-cationic lipid complexation,
Mikko Karttunen, Antti L. Pakkanen, Paavo K.J. Kinnunen, and Kimmo Kaski,
Cell. Mol. Biol. Lett., 7, 238 (2002).
- See our publication list.
General references:
- M. S. Spector, J. M. Schnur, Science 275 (1997) 791-792
- T. Paukku, S. Lauraeus, I. Huhtaniemi, P. K. J. Kinnunen, Chemistry
and Physics of Lipids 87 (1997) 23-29
- P. L. Felgner, T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J.
P. Northrop, G. M. Ringold, M. Danielsen, Proceedings of the National
Academy of Sciences of the United States of America 84 (1987) 7413-7417
- J. Zabner, A. J. Fasberder, T. Moniger, K. A. Poellinger, M. J. Welsh,
The Journal of Biological Chemistry 270 (1995) 18997-19007
- R. Zantl, L. Baicu, F. Artzner, I. Sprenger, G. Rapp, J. O. Rädler,
Journal of Physical Chemistry B 103 (1999) 10300-10310
- P. G. Scherer, J. Seelig, Biochemistry 28 (1989) 7720-7728
- J. Seelig, P. M. Macdonald, P. G. Scherer, Biochemisry 26 (1987)
7535-7541
- N. Dan, Biophysical Journal 73 (1997) 1842-1846
- S. May, D. Harries, A. Ben-Shaul, Biophysical Journal 78 (2000)
1681-1697
- W. M. Gelbart, R. F. Bruinsma, P. A. Pincus, V. A. Parsegian, Physics
Today 53 (2000) 38-44
- S. Badhyopadhyay, M. Tarek, M. L. Klein, The Journal of Physical
Chemistry B 103 (1999) 10075-10080
- S. W. Chiu, E. Jakobsson, S. Subramaniam, H. L. Scott, Biophysical
Journal 77 (1999) 2462-2469
- P. Jedlovszky, M. Mezei, Journal of Chemical Physics 111 (1999)
10770-10773
- E. W. f. W. Alton, M. Stern, R. Farley, A. Jaffe, S. L. Chadwick, J.
Phillips, J. Davies, S. N. Smith, J. Browning, M. G. Davies, M. E. Hodson,
S. R. Durham, D. Li, P. K. Jeffery, M. Scallan, R. Balfour, S. J. Eastman,
S. H. Cheng, A. E. Smith, D. Meeker, D. M. Geddes, The Lancet 353 (1999)
947-954
- N. J. Caplen, E. W. F. W. Alton, P. G. Middleton, J. R. Dorin, B. J.
Stevenson, X. Gao, S. R. Durham, P. K. Jefery, M. E. Hodson, C. Coutelle,
L. Huang, D. J. Porteous, R. Williamson, D. M. Geddes, Nature Medicine 1
(1995) 39-46
|
|